These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. CD34-selected versus unmanipulated autologous haematopoietic stem cell transplantation in the treatment of severe systemic sclerosis: a post hoc analysis of a phase I/II clinical trial conducted in Japan. Ayano M; Tsukamoto H; Mitoma H; Kimoto Y; Akahoshi M; Arinobu Y; Miyamoto T; Horiuchi T; Niiro H; Nagafuji K; Harada M; Akashi K Arthritis Res Ther; 2019 Jan; 21(1):30. PubMed ID: 30670057 [TBL] [Abstract][Full Text] [Related]
6. Autologous stem cell transplantation for progressive systemic sclerosis: a prospective non-interventional study from the European Society for Blood and Marrow Transplantation Autoimmune Disease Working Party. Henes J; Oliveira MC; Labopin M; Badoglio M; Scherer HU; Del Papa N; Daikeler T; Schmalzing M; Schroers R; Martin T; Pugnet G; Simoes B; Michonneau D; Marijt EWA; Lioure B; Olivier Bay J; Snowden JA; Rovira M; Huynh A; Onida F; Kanz L; Marjanovic Z; Farge D Haematologica; 2021 Feb; 106(2):375-383. PubMed ID: 31949011 [TBL] [Abstract][Full Text] [Related]
7. Long-term follow-up results after autologous haematopoietic stem cell transplantation for severe systemic sclerosis. Vonk MC; Marjanovic Z; van den Hoogen FH; Zohar S; Schattenberg AV; Fibbe WE; Larghero J; Gluckman E; Preijers FW; van Dijk AP; Bax JJ; Roblot P; van Riel PL; van Laar JM; Farge D Ann Rheum Dis; 2008 Jan; 67(1):98-104. PubMed ID: 17526554 [TBL] [Abstract][Full Text] [Related]
8. Optimization of autologous stem cell transplantation for systemic sclerosis -- a single-center longterm experience in 26 patients with severe organ manifestations. Henes JC; Schmalzing M; Vogel W; Riemekasten G; Fend F; Kanz L; Koetter I J Rheumatol; 2012 Feb; 39(2):269-75. PubMed ID: 22247352 [TBL] [Abstract][Full Text] [Related]
17. Predictive factors for treatment-related mortality and major adverse events after autologous haematopoietic stem cell transplantation for systemic sclerosis: results of a long-term follow-up multicentre study. van Bijnen S; de Vries-Bouwstra J; van den Ende CH; Boonstra M; Kroft L; Geurts B; Snoeren M; Schouffoer A; Spierings J; van Laar JM; Huizinga TW; Voskuyl A; Marijt E; van der Velden W; van den Hoogen FH; Vonk MC Ann Rheum Dis; 2020 Aug; 79(8):1084-1089. PubMed ID: 32409324 [TBL] [Abstract][Full Text] [Related]
18. Randomized Phase III BMT CTN Trial of Calcineurin Inhibitor-Free Chronic Graft-Versus-Host Disease Interventions in Myeloablative Hematopoietic Cell Transplantation for Hematologic Malignancies. Luznik L; Pasquini MC; Logan B; Soiffer RJ; Wu J; Devine SM; Geller N; Giralt S; Heslop HE; Horowitz MM; Jones RJ; Litzow MR; Mendizabal A; Muffly L; Nemecek ER; O'Donnell L; O'Reilly RJ; Palencia R; Schetelig J; Shune L; Solomon SR; Vasu S; Ho VT; Perales MA J Clin Oncol; 2022 Feb; 40(4):356-368. PubMed ID: 34855460 [TBL] [Abstract][Full Text] [Related]
19. Long term outcomes of the French ASTIS systemic sclerosis cohort using the global rank composite score. Ait Abdallah N; Wang M; Lansiaux P; Puyade M; Berthier S; Terriou L; Charles C; Burt RK; Hudson M; Farge D Bone Marrow Transplant; 2021 Sep; 56(9):2259-2267. PubMed ID: 34108673 [TBL] [Abstract][Full Text] [Related]
20. [The arguments favoring autologous haematopoietic stem cell transplantation in systemic scleroderma]. Pugnet G Rev Med Interne; 2024 Feb; 45(2):104-108. PubMed ID: 38267322 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]